Abstract:The poor solubility of integral membrane proteins in water frequently hinders studies with these proteins, presenting challenges for structure determination and binding screens. For instance, the transmembrane protein CD20, which is an important target for treating B-cell malignancies, is not soluble in water and cannot be easily screened against potential protein binders with techniques like phage display or yeast display. Here, we use de novo protein design to create a water-soluble mimic of the CD20 dimer (soluble CD20). Soluble CD20 replaces the central transmembrane helix of CD20 with a water- soluble helix that dimerizes to form a coiled coil that structurally matches the dimer interface of native CD20 and presents the central extracellular loop of CD20 in a binding competent conformation. Unlike peptides derived from CD20, soluble CD20 binds tightly to monoclonal antibodies that recognize quaternary epitopes on the extracellular face of CD20. We demonstrate that soluble CD20 is easy to produce, remains folded above 60C, and is compatible with binder screening via yeast display. Our results highlight the ability of computational protein design to scaffold conformational epitopes from membrane proteins for use in binding and protein engineering studies.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to design a water - soluble CD20 antigen mimic for antibody screening and other biochemical studies in vitro experiments. Specifically, due to the low solubility of membrane proteins (such as CD20) in water, this greatly limits the structural determination and binding screening studies of these proteins. CD20 is an important target for treating B - cell malignancies, but its water - insoluble property makes it difficult to screen it through high - throughput techniques (such as phage display or yeast display). To solve this problem, the researchers used the method of computational protein design to design a new protein - "soluble CD20". This protein replaces the transmembrane helix in the center of CD20 with a water - soluble helix to form a coiled - coil structure, which structurally matches the dimer interface of natural CD20 and can present the central extracellular loop of CD20 in a binding - active conformation. Compared with peptides derived from CD20, this water - soluble CD20 can tightly bind monoclonal antibodies that recognize the quaternary epitope on the extracellular surface of CD20. The paper also shows that this water - soluble CD20 is easy to produce, has good thermal stability (above 60 °C), and is suitable for binding screening through yeast display. The research results indicate that computational protein design can be used to construct conformational epitope scaffolds of membrane proteins, which is very useful for binding and protein engineering studies. Overall, this study shows that through computational protein design methods, water - soluble variants of membrane proteins can be created, and these variants are compatible with high - throughput binding screening techniques, which is of great significance for the development of next - generation anti - CD20 therapies.

Design of a Water-Soluble CD20 Antigen with Computational Epitope Scaffolding

Chemical Remodeling Cell Surface Glycans for Immunotargeting of Tumor Cells

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

Fine Epitope Mapping of the CD19 Extracellular Domain Promotes Design

Computational design of soluble and functional membrane protein analogues

Better Prior Distribution for Antibody Complementarity-Determining Regions Design

Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers

A Versatile Chemo-Enzymatic Conjugation Approach Yields Homogeneous and Highly Potent Antibody-Drug Conjugates.

Computational design of soluble functional analogues of integral membrane proteins

Computational Design of an Epitope-Specific Keap1 Binding Antibody Using Hotspot Residues Grafting and CDR Loop Swapping

Design of High Affinity Binders to Convex Protein Target Sites

Enhancing Protein Solubility Via Glycosylation: from Chemical Synthesis to Machine Learning Predictions

Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations

Semiautomated design and soluble expression of a chimeric antigen TbpAB01 from Glaesserella parasuis

Atomically accurate de novo design of single-domain antibodies

De novo design of drug-binding proteins with predictable binding energy and specificity

Combinatorially restricted computational design of protein-protein interfaces to produce IgG heterodimers

De novo design of ErbB2 epitope targeting fusion protein stabilized by coiled coil structure.

Computational design of BclxL inhibitors that target transmembrane domain interactions

IsAb: a computational protocol for antibody design

De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics